24小时热门版块排行榜

>论坛更新日志 (3378)
>虫友互识 (270)
>导师招生 (213)
>文献求助 (146)
>考研 (109)
>公派出国 (74)
>招聘信息布告栏 (55)
>硕博家园 (53)
>考博 (45)
>博后之家 (43)
>论文投稿 (42)
>休闲灌水 (34)
>基金申请 (22)
>教师之家 (20)
>无机非金属 (18)
>找工作 (16)

南方科技大学公共卫生及应急管理学院2025级博士研究生招生报考通知

返回列表

【奖励】本帖被评价58次，作者yuanbing000增加金币 45.4 个

yuanbing000

新虫 (小有名气)

应助: 0 (幼儿园)
金币: 852.7
帖子: 98
在线: 51.1小时
虫号: 2718204

[资源] 20160309 ECA新闻：FDA关于溶出测试的指南

20160309 ECA新闻：FDA关于溶出测试的指南
GMP News
09/03/2016

FDA Guideline on Dissolution Testing

FDA关于溶出测试的指南

In August 2015, the FDA published the draft of a guideline on dissolution testing for immediate release solid oral dosage forms. It is planned that after its finalisation, a part of this guideline will replace the current guideline from August 1997.

在2015年8月，FDA公布了即释固体口服制剂的溶出度测试指南草案。FDA计划在其定稿后，此指南的一部分将替代自1997年8月开始实施的现行指南。

The Biopharmaceutics Classification System (BCS) distinguishes 4 different classes of APIs depending on their solubility and permeability.

生物药品分类系统（BCS）根据其溶解度和渗透性将原料药分为4类。

On the basis of this classification, a decision can be taken for determining when bioavailability or bioequivalence studies are required, or when a successful in vitro-in vivo correlation (IVIVC) is likely.

在此分类基础上，可以决定什么时候需要进行生物利用度或生物等效性研究，什么时候体内体外试验（IVIVC）能成功对应。

The BCS proposes that, for certain medicinal products which contain a high soluble API, dissolution testing can be standardised. Due to their high solubility, medicinal products in the BCS classes 1 and 3 have a relatively low risk with regard to the impact on dissolution, provided that the in vitro performance meets or exceeds the recommendations given.

BCS提议对于特定的药品，如果含有可溶的原料药，其溶出度测试可以标准化。由于在BCS一类和三类的药品具有较高的溶解度，如果体外表现符合或超出所给出的建议，则其对溶出的影响风险相对较低。

If these conditions are met, the new guideline will provide concrete provisions regarding the methods which can be standardised: USP apparatus 1 (basket method) or 2 (paddle method) with fixed parameters for stirring rate, medium and temperature. For this, the permitted limits for the specifications are laid down. In addition, the possibility is granted that, under certain conditions, disintegration testing can be used as alternative method.

如果符合这些条件，则新指南会提供一个具体的方法标准化条款：USP仪器1（转篮法）或2（桨法），配有固定的搅拌速度参数，介质和温度。对此，界定了质量标准所允许的限度。另外，在固定条件下，可以保证崩解试验可以用作替代方法。

You can access the complete document of the FDA "Dissolution Testing and Specification Criteria for Immediate Release Solid Oral Dosage Forms" here.

你可以在上述网址找到FDA的指南全本。

回复此楼